Evidence that the major degradation product of glucose-dependent insulinotropic polypeptide, GIP(3-42), is a GIP receptor antagonist in vivo

Victor Gault, JC Parker, P Harriott, Peter Flatt, Finbarr O'Harte

Research output: Contribution to journalArticlepeer-review

85 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Evidence that the major degradation product of glucose-dependent insulinotropic polypeptide, GIP(3-42), is a GIP receptor antagonist in vivo'. Together they form a unique fingerprint.

Medicine & Life Sciences